Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2024
Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and TaperingClarissa Q Pimentel, Ana Cristina Medeiros-Ribeiro, Andrea Y Shimabuco, et al.Clinics (Sao Paulo, Brazil)|October 21, 2009
Guidelines on management of human infection with the novel virus influenza A (H1N1)--a report from the Hospital das Clínicas of the University of São PauloLudhmila Abrahao Hajjar, Denise Schout, Filomena Regina Barbosa Gomes Galas, et al.Clinics (Sao Paulo, Brazil)|October 21, 2009
Epidemiology of human infection with the novel virus influenza A (H1N1) in the Hospital das Clínicas, São Paulo, Brazil--June-September 2009Denise Schout, Ludhmila Abrahao Hajjar, Filomena Regina Barbosa Gomes Galas, et al.The Journal of Rheumatology|April 10, 2008
Pregnancy outcome in juvenile systemic lupus erythematosus: a Brazilian multicenter cohort studyClovis A A Silva, Maria O Hilario, Marilia V Febronio, et al.Brain, Behavior, and Immunity|December 26, 2021
Association between physical activity and immunogenicity of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseasesBruno Gualano, Italo R Lemes, Rafael P Silva, et al.Annals of the Rheumatic Diseases|February 23, 2022
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trialCarlo Scognamiglio Renner Araujo, Ana Cristina Medeiros-Ribeiro, Carla G S Saad, et al.Clinics (Sao Paulo, Brazil)|November 4, 2020
Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic areaAndrea Yukie Shimabuco, Ana Cristina de Medeiros-Ribeiro, Renata Miossi, et al.Journal of Physical Activity & Health|March 4, 2023
Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic DiseasesBruno Gualano, Sofia M Sieczkowska, Ítalo Ribeiro Lemes, et al.Annals of the Rheumatic Diseases|August 24, 2011
Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practiceAna C M Ribeiro, Lissiane K N Guedes, Julio C B Moraes, et al.Rheumatology (Oxford, England)|February 3, 2012
Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?Eduardo F Borba, Carla G S Saad, Sandra G Pasoto, et al.Pageof 11